Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haseebullah Baha

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Viruses|May 27, 2023
Interactions of Equine Viruses with the Host Kinase Machinery and Implications for One Health and Human DiseaseCarol Anderson, Haseebullah Baha, Niloufar Boghdeh, et al.
Plos Pathogens|April 8, 2025
Capture of fusion-intermediate conformations of SARS-CoV-2 spike requires receptor binding and cleavage at either the S1/S2 or S2' siteSabrina Lusvarghi, Russell Vassell, Brittany Williams, et al.
Briefings in Bioinformatics|January 29, 2025
Classification-based pathway analysis using GPNet with novel P-value computationHao Lu, Mostafa Rezapour, Haseebullah Baha, et al.
Viruses|November 27, 2024
Host-Driven Ubiquitination Events in Vector-Transmitted RNA Virus Infections as Options for Broad-Spectrum Therapeutic Intervention StrategiesSanskruthi Sreepangi, Haseebullah Baha, Lorreta Aboagyewa Opoku, et al.
Journal of Virology|August 24, 2022
Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 VariantsSabari Nath Neerukonda, Richard Wang, Russell Vassell, et al.
Plos Pathogens|November 9, 2023
Effects of N-glycan modifications on spike expression, virus infectivity, and neutralization sensitivity in ancestral compared to Omicron SARS-CoV-2 variantsSabrina Lusvarghi, Charles B Stauft, Russell Vassell, et al.
Viruses|March 30, 2023
Inhibitors of the Ubiquitin-Mediated Signaling Pathway Exhibit Broad-Spectrum Antiviral Activities against New World AlphavirusesNiloufar A Boghdeh, Brittany McGraw, Michael D Barrera, et al.
ACS Infectious Diseases|December 31, 2024
nsP2 Protease Inhibitor Blocks the Replication of New World Alphaviruses and Offer Protection in MiceOlawale S Adeyinka, Michael D Barrera, Damilohun S Metibemu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Viruses|May 27, 2023
Interactions of Equine Viruses with the Host Kinase Machinery and Implications for One Health and Human DiseaseCarol Anderson, Haseebullah Baha, Niloufar Boghdeh, et al.
Plos Pathogens|April 8, 2025
Capture of fusion-intermediate conformations of SARS-CoV-2 spike requires receptor binding and cleavage at either the S1/S2 or S2' siteSabrina Lusvarghi, Russell Vassell, Brittany Williams, et al.
Briefings in Bioinformatics|January 29, 2025
Classification-based pathway analysis using GPNet with novel P-value computationHao Lu, Mostafa Rezapour, Haseebullah Baha, et al.
Viruses|November 27, 2024
Host-Driven Ubiquitination Events in Vector-Transmitted RNA Virus Infections as Options for Broad-Spectrum Therapeutic Intervention StrategiesSanskruthi Sreepangi, Haseebullah Baha, Lorreta Aboagyewa Opoku, et al.
Journal of Virology|August 24, 2022
Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 VariantsSabari Nath Neerukonda, Richard Wang, Russell Vassell, et al.
Plos Pathogens|November 9, 2023
Effects of N-glycan modifications on spike expression, virus infectivity, and neutralization sensitivity in ancestral compared to Omicron SARS-CoV-2 variantsSabrina Lusvarghi, Charles B Stauft, Russell Vassell, et al.
Viruses|March 30, 2023
Inhibitors of the Ubiquitin-Mediated Signaling Pathway Exhibit Broad-Spectrum Antiviral Activities against New World AlphavirusesNiloufar A Boghdeh, Brittany McGraw, Michael D Barrera, et al.
ACS Infectious Diseases|December 31, 2024
nsP2 Protease Inhibitor Blocks the Replication of New World Alphaviruses and Offer Protection in MiceOlawale S Adeyinka, Michael D Barrera, Damilohun S Metibemu, et al.
Pageof 1